Article info
Original article
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient’s satisfaction
- Correspondence to Mrs. Ana María Horta-Hernández, Pharmacy Department, Hospital Universitario de Guadalajara, Guadalajara 19002, Spain; amhorta{at}sescam.jccm.es
Citation
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient’s satisfaction
Publication history
- Received January 10, 2018
- Revised March 13, 2018
- Accepted April 10, 2018
- First published April 28, 2018.
Online issue publication
August 30, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.